Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

An evaluation of secondary prophylaxis for rheumatic heart disease in rural Egypt.

Balbaa A, ElGuindy A, Pericak D, Yacoub MH, Schwalm JD.

Glob Cardiol Sci Pract. 2015 Oct 17;2015(3):40. doi: 10.5339/gcsp.2015.40. eCollection 2015.

2.

Radial artery versus femoral artery access options in coronary angiogram procedures: randomized controlled trial of a patient-decision aid.

Schwalm JD, Stacey D, Pericak D, Natarajan MK.

Circ Cardiovasc Qual Outcomes. 2012 May;5(3):260-6. doi: 10.1161/CIRCOUTCOMES.111.962837. Epub 2012 Apr 10.

PMID:
22496115
3.

Long-term outcomes with paclitaxel-eluting stents versus bare metal stents in everyday practice: a Canadian experience.

Schwalm JD, Ahmad M, Velianou JL, Pericak D, Natarajan MK.

Can J Cardiol. 2010 Feb;26(2):e40-4.

4.

Comparison of one-year clinical outcomes with paclitaxel-eluting stents versus bare metal stents in everyday practice.

Ahmad M, Schwalm JD, Velianou JL, Pericak D, Natarajan MK.

Can J Cardiol. 2008 Oct;24(10):771-5.

5.

Validation of a prediction model to estimate health utilities index Mark 3 utility scores from WOMAC index scores in patients with osteoarthritis of the hip.

Marshall D, Pericak D, Grootendorst P, Gooch K, Faris P, Frank C, Bellamy N, Torrance G, Feeny D.

Value Health. 2008 May-Jun;11(3):470-7. doi: 10.1111/j.1524-4733.2007.00258.x.

6.

A model to estimate health utilities index mark 3 utility scores from WOMAC index scores in patients with osteoarthritis of the knee.

Grootendorst P, Marshall D, Pericak D, Bellamy N, Feeny D, Torrance GW.

J Rheumatol. 2007 Mar;34(3):534-42.

PMID:
17343301
7.

BLISS index for analyzing knee osteoarthritis trials data.

Bellamy N, Bell MJ, Pericak D, Goldsmith CH, Torrance GW, Raynauld JP, Walker V, Tugwell P, Polisson R.

J Clin Epidemiol. 2007 Feb;60(2):124-32. Epub 2006 Aug 30.

PMID:
17208118
8.

Economic evaluation of controlled-release oxycodone vs oxycodone-acetaminophen for osteoarthritis pain of the hip or knee.

Marshall DA, Strauss ME, Pericak D, Buitendyk M, Codding C, Torrance GW.

Am J Manag Care. 2006 Apr;12(4):205-14.

9.

Effectiveness and safety of repeat courses of hylan G-F 20 in patients with knee osteoarthritis.

Raynauld JP, Goldsmith CH, Bellamy N, Torrance GW, Polisson R, Belovich D, Pericak D, Tugwell P.

Osteoarthritis Cartilage. 2005 Feb;13(2):111-9.

10.

The effectiveness of hylan G-F 20 in patients with knee osteoarthritis: an application of two sets of response criteria developed by the OARSI and one set developed by OMERACT-OARSI.

Bellamy N, Bell MJ, Goldsmith CH, Pericak D, Walker V, Raynauld JP, Torrance GW, Tugwell P, Polisson R.

Osteoarthritis Cartilage. 2005 Feb;13(2):104-10.

11.

Evaluation of WOMAC 20, 50, 70 response criteria in patients treated with hylan G-F 20 for knee osteoarthritis.

Bellamy N, Bell MJ, Goldsmith CH, Pericak D, Walker V, Raynauld JP, Torrance GW, Tugwell P, Polisson R.

Ann Rheum Dis. 2005 Jun;64(6):881-5. Epub 2004 Nov 25.

12.

Incidence, predictors, and clinical significance of troponin-I elevation without creatine kinase elevation following percutaneous coronary interventions.

Natarajan MK, Kreatsoulas C, Velianou JL, Mehta SR, Pericak D, Goodhart DM.

Am J Cardiol. 2004 Mar 15;93(6):750-3.

PMID:
15019884
13.
14.

Validation of the GSFQ, a self-administered symptom frequency questionnaire for patients with gastroesophageal reflux disease.

Paré P, Meyer F, Armstrong D, Pyzyk M, Pericak D, Goeree R.

Can J Gastroenterol. 2003 May;17(5):307-12.

PMID:
12772004
15.
16.

Evaluation of the role of abciximab (Reopro) as a rescue agent during percutaneous coronary interventions: in-hospital and six-month outcomes.

Velianou JL, Strauss BH, Kreatsoulas C, Pericak D, Natarajan MK.

Catheter Cardiovasc Interv. 2000 Oct;51(2):138-44.

PMID:
11025564
17.

Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity.

Cook RJ, Gladman DD, Pericak D, Urowitz MB.

J Rheumatol. 2000 Aug;27(8):1892-5.

PMID:
10955329
18.

Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure.

Suskin N, McKelvie RS, Burns RJ, Latini R, Pericak D, Probstfield J, Rouleau JL, Sigouin C, Solymoss CB, Tsuyuki R, White M, Yusuf S.

Eur Heart J. 2000 Aug;21(16):1368-75.

PMID:
10952826
19.

Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators.

McKelvie RS, Yusuf S, Pericak D, Avezum A, Burns RJ, Probstfield J, Tsuyuki RT, White M, Rouleau J, Latini R, Maggioni A, Young J, Pogue J.

Circulation. 1999 Sep 7;100(10):1056-64.

PMID:
10477530

Supplemental Content

Loading ...
Support Center